StopAfib.org Speaks on Behalf of Atrial Fibrillation Patients at FDA Hearing on Amiodarone Replacement

On March 18, 2009, StopAfib.org represented the atrial fibrillation patient community at the FDA Cardiovascular and Renal Drugs Advisory Committee hearings on a replacement for amiodarone. We greatly appreciate you sharing your many stories so that we could share your experiences with the FDA. I had promised to share my comments with the afib patient community, and you’ll find them here along with a summary of the hearing:

StopAfib.org Speaks on Behalf of the Atrial Fibrillation Community at FDA Hearing